Skip to main content

SWK Holdings Corp

corporate_fare Company Profile

SWK Holdings Corp

SWKH·NASDAQ·Finance·CIK 0001089907

SWK Holdings Corp operates as a specialty finance and asset management business, with a focus on the healthcare sector. The company commenced its specialty finance and asset management strategy in July 2012. Prior to September 30, 2025, its operations included two reportable segments: "Finance Receivables" and "Pharmaceutical Development." Following the sale of substantially all assets of the Pharmaceutical Development segment, the Finance Receivables segment will be the sole operating segment in subsequent years. SWK Holdings Corp evaluates and invests in a wide range of healthcare-related companies and products with innovative intellectual property, spanning the biotechnology, medical device, medical diagnostics and related tools, animal health, and pharmaceutical industries, collectively referred to as "life sciences." The company allocates capital within its finance receivables portfolio to generate income from the sales of life science products by third parties and related earned income sources. The Finance Receivables segment aims to be a leading healthcare capital provider by offering customized financing solutions to life science companies, institutions, and inventors. This segment primarily monetizes cash flow streams from commercial-stage products and related intellectual property through royalty purchases and financings, and by creating synthetic revenue interests in commercialized products. Business partners are primarily involved in selling products that treat diseases or improve the wellness of people or animals, or they receive royalties from such product sales. For instance, biotechnology and pharmaceutical partners commercialize medicines, while life science tools partners sell research instrumentation for clinical research. The company earns interest, fees, and other income through this strategy and continuously seeks financing opportunities tailored to its partners' needs. SWK Holdings Corp serves an underserved niche in the sub-$50.0 million transaction size market. The company is headquartered in Dallas, Texas.

SWK Holdings Corp (NASDAQ:SWKH) is a publicly traded company in the Finance sector. Wiseek monitors SWKH SEC EDGAR filings and licensed market news in real time, scoring each submission for market-moving significance on a 1–10 scale. Items rated 7 or higher generate instant alerts.

Recent high-impact activity:

  • SWK Holdings Completes Merger with Runway Growth Finance, Delists from Nasdaq
  • SWK Holdings Stockholders Approve Merger with Runway Growth Finance
  • SWK Holdings Stockholders Approve Merger with Runway Growth Finance
  • SWK Holdings Faces Merger Litigation and Reduced Liquidity Amidst Pending Acquisition by Runway Growth Finance
  • SWK Holdings Amends Credit Agreement, Reduces Facility to $7.5M and Adjusts Covenants
Browse all tickers starting with S →
$15.9
52-week range · as of 2026-04-06 $13.17 – $20.49
Market cap
$192.33M
Volume
105.6K (8.2× avg)
3-mo avg 12.9K
Live data · 2026-06-13 13:34 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed SWKH - Latest Insights

SWKH
Apr 06, 2026, 11:39 AM EDT
Filing Type: 8-K
Importance Score:
10
Price at Filing: $15.90
Real-time Price: $15.90 info
Change: $0 (0%) info
Market Cap: $192.326M info
SWKH
Mar 31, 2026, 4:15 PM EDT
Filing Type: 425
Importance Score:
8
Price at Filing: $17.01
Real-time Price: $15.90 info
Change: -$1.11 (-7%) info
Market Cap: $192.326M info
SWKH
Mar 31, 2026, 4:15 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $17.01
Real-time Price: $15.90 info
Change: -$1.11 (-7%) info
Market Cap: $192.326M info
SWKH
Mar 20, 2026, 4:30 PM EDT
Filing Type: 10-K
Importance Score:
9
Price at Filing: $16.51
Real-time Price: $15.90 info
Change: -$0.610 (-4%) info
Market Cap: $192.326M info
SWKH
Feb 13, 2026, 4:38 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $17.00
Real-time Price: $15.90 info
Change: -$1.10 (-6%) info
Market Cap: $192.326M info